Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata?

OBJECTIVE: To evaluate if pelvic magnetic resonance imaging (MRI) is reliable for differentiating leiomyoma subtypes. DESIGN: Prospective study. SETTING: Academic center. PATIENT(S): Forty-five patients underwent MRI before surgery for leiomyomata. INTERVENTION(S): One radiologist blinded to patient history and histologic diagnosis recorded the MRI characteristics and classification of the largest leiomyoma. MAIN OUTCOME MEASURE(S): Comparison of MRI and histologic diagnoses. RESULT(S): Leiomyoma subtypes were diagnosed accurately by MRI in 69% of cases. Magnetic resonance imaging had a 95% sensitivity and 72% specificity for diagnosing an uncomplicated leiomyoma and a 10% sensitivity and 100% specificity for a cellular leiomyoma. For cystic leiomyomata, the sensitivity was 80% and specificity was 98%, and for hemorrhagic leiomyomata, 100% and 86%, respectively. Magnetic resonance imaging correctly diagnosed all malignant tumors and did not incorrectly diagnose a leiomyoma as a leiomyosarcoma in any case. Ill-defined MRI margins were significantly more likely to be leiomyosarcoma, whereas well-defined margins were characteristic of benign lesions. Hemorrhagic leiomyomata were significantly more likely to be hyperintense on T1-weighted images than other subtypes. CONCLUSION(S): Although MRI is only fairly accurate in differentiating the subtypes of benign uterine smooth muscle tumors, signal intensities and margin characteristics are useful to distinguish accurately benign from malignant tumors.

Life-threatening pulmonary hemorrhage with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia.

The occurrence of significant pulmonary hemorrhage associated with pulmonary arteriovenous malformations (PAVMs) and hereditary hemorrhagic telangiectasia (HHT) and the incidence of PAVMs in family members of patients with PAVMs and HHT are poorly defined. We reviewed our experience in 143 patients with PAVMs and HHT. Eleven (8 percent) of the 143 patients with HHT and PAVMs had a history of either massive hemoptysis or of hemothorax which required hospitalization. One patient died directly related to the pulmonary hemorrhage. There were four men and seven women. Three of the seven women experienced pulmonary hemorrhage during pregnancy. Seven of the 11 families participated in screening for PAVMs. Thirty-six (80 percent) of the 45 screened family members were found to have HHT. Thirteen (36 percent) of the 36 family members with HHT were proven to have PAVMs by pulmonary angiography. Pulmonary hemorrhage due to spontaneous rupture of the PAVM is a potentially life-threatening complication that should be treated aggressively with transcatheter embolotherapy. It occurs more frequently than previously recognized in patients with PAVMs and HHT. In addition, because of the increased incidence of PAVMs in family members of patients with HHT and PAVM, screening of family members with HHT is recommended especially in women of childbearing age.

Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging.

The utility of magnetic resonance (MR) imaging in assessing response to therapy with a gonadotropin-releasing hormone (GnRH) analog was assessed in 19 women with uterine leiomyomas and 19 women with endometriosis. There was a significant reduction in individual fibroid volumes at 3 months (P less than .05) and at 6 months (P less than .005) in the drug group, whereas there was no significant change in the placebo group. Vessel conspicuity significantly decreased at 3 months (P less than .02) and at 6 months (P less than .01) in the drug group but not in the placebo group. In the patients with endometriosis, there was a significant decrease (P less than .0006) in the number of endometriomas visualized. Significant changes were also noted in the pelvis in women who were receiving the GnRH analog. After 6 months of therapy, the identifiability of the ovaries was significantly poorer (P less than .05). The authors conclude that the utility of conservative therapy with a GnRH analog can be quantitatively assessed with MR imaging.

Doppler US. Part II. Clinical applications.

Duplex and color Doppler ultrasound (US) are noninvasive techniques capable of providing much information about the condition of blood vessels and flow within them throughout the body. Doppler US provides more than noninvasive angiography. Besides assessment of blood vessel patency and direction of flow, analysis of the flow velocity waveform allows quantitation of arterial stenoses and evaluation of both physiologic and pathologic changes in impedance. In certain situations, Doppler US can aid in tissue characterization and estimation of absolute flow volume. Color Doppler flow imaging may both expedite and clarify the duplex Doppler examination. In addition, color Doppler imaging can demonstrate flow orientation and improve the identification of turbulence and soft plaque. Color and duplex Doppler US are complementary, with color Doppler techniques providing spatial orientation and pulse Doppler techniques providing the time-velocity spectrum for quantitation.

High-field MRI and US evaluation of the pelvis in women with leiomyomas.

Magnetic resonance imaging (MRI) and real-time transabdominal ultrasonography (US) were performed on 23 women with uterine leiomyomas. The uterus, ovaries, and cul de sac were evaluated. Accurate determination of uterine volume was possible in all cases by MRI, but was limited on US in uteri larger than 140 cc. Marked enlargement also prevented visualization of contour abnormalities in eight patients on US, but none on MRI. The endometrial stripe and junctional zone could not be adequately visualized in 21/23 US examinations, whereas they were identified in all 23 MRI (8 normal and 15 distorted). Individual leiomyomas were clearly depicted on 4 US and 19 MR scans, the smallest being 1.1 cm and 0.8 cm, respectively. Of the 31 fibroids present on MRI: 13 were intramural, 4 subserosal, and 14 submucosal. MRI successfully identified 44/46 ovaries as compared to 21/46 on US. Cul de sac fluid was noted in seven women by MRI alone. This data suggests that MRI is superior to US in examination of the entire pelvis in women with leiomyomas.

Endometriosis: appearance and detection at MR imaging.

Thirty-nine magnetic resonance (MR) studies were performed on 31 women with surgically proved endometriosis. A total of 88 endometriotic lesions ranging in size from 0.2 to 7.5 cm were detected on 24 of 30 MR images of women. The signal intensities ranged from hyperintense on all pulse sequences (41 of 88) to hypointense on all sequences (24 of 88); the remainder demonstrated signal intensities corresponding to the appearances of acute, subacute, and chronic hematomas. Hypointense or signal-void rims on both T1- and T2-weighted images were detected in 35 lesions. Identification of the disease with MR imaging versus concurrent surgery was compared for 76 sites in 19 patients. Findings were true-positive in 24 cases, false-negative in ten, true-negative in 32, and false-positive in seven, resulting in an MR sensitivity of 71% and specificity of 82%. Adhesions obscured the disease at laparoscopy in three patients. MR imaging cannot be used as a substitute for laparoscopy in the definitive diagnosis or staging of endometriosis. However, it can be used to monitor treatment response in place of laparoscopy once a diagnosis is firmly established.

Candida epiglottitis in an adult with acute nonlymphocytic leukemia.

A 40-year-old white woman presented with fever, otalgia, and odynophagia and was found to have a peripheral white blood cell count of 90,000/mm3. A diagnosis of acute myelogenous leukemia was made. Further evaluation of symptoms and source for fever led to the diagnosis of Candida albicans epiglottitis. This is the first reported case of fungal epiglottitis in an immunocompromised adult.